Compare AstraZeneca plc (AZN) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Wayfair Inc — how do they compare? AstraZeneca plc trades at $158.09 (market cap $248.14B), while Wayfair Inc trades at $103.55 (market cap $14.14B). The key difference: AstraZeneca plc is far larger — about 17.5× Wayfair Inc's market cap, and AstraZeneca plc pays a 2.01% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals.
| AZN | W | |
|---|---|---|
Market Cap | $248.14B | $14.14B |
Sector | Health | Consumer Cyclical |
52-Week High | $209.48 | $119.05 |
52-Week Low | $147.06 | $57.40 |
Enterprise Value | $275.41B | $16.47B |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
